XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows From Operating Activities:    
Net income (loss) $ 21,721,858 $ (2,334,110)
Adjustments to reconcile net income (loss) to net cash flows used in operating activities:    
Depreciation and amortization 55,422 72,941
Stock based compensation 326,164 311,677
Change in fair value of warrant derivative liabilities (24,552,257)
Provision for inventory obsolescence 427,907 285,130
Amortization of discount on unsecured promissory notes 86,867
Change in fair value of secured convertible notes 412,445
Change in fair value of proceeds investment agreement (307,000)
(Increase) decrease in:    
Accounts receivable - trade 574,072 (467,469)
Accounts receivable - other (379,472) (44,033)
Inventories (1,115,549) (142,604)
Prepaid expenses 200,027 (39,722)
Operating lease right of use assets 4,434 28,010
Other assets (187,291) (12,752)
Increase (decrease) in:    
Accounts payable (478,608) (34,915)
Accrued expenses 69,630 112,769
Operating lease obligations (15,451) (109,172)
Contract liabilities 142,270 137,486
Net cash used in operating activities (3,206,844) (2,044,452)
Cash Flows from Investing Activities:    
Purchases of furniture, fixtures and equipment (77,011) (1,666)
Additions to intangible assets (22,263) (28,997)
Net cash used in investing activities (99,274) (30,663)
Cash Flows from Financing Activities:    
Proceeds from unsecured promissory note payable, related party 289,000
Proceeds from unsecured promissory note payable 100,000
Net proceeds from sale of common stock in registered direct offerings 13,346,600 2,502,136
Proceeds from issuance of common stock upon exercise of pre-funded warrants 53,224,000
Principal payment on subordinated notes payable (100,000)
Principal payment on secured convertible notes (747,180)
Net cash provided by financing activities 66,570,600 2,043,956
Net increase/(decrease) in cash and cash equivalents 63,264,482 (31,159)
Cash, cash equivalents, beginning of period 4,361,758 359,685
Cash, cash equivalents, end of period 67,626,240 328,526
Supplemental disclosures of cash flow information:    
Cash payments for interest 119,835
Cash payments for income taxes
Supplemental disclosures of non-cash investing and financing activities:    
Restricted common stock grant 450 530
Restricted common stock forfeitures 8 23
Amounts allocated to initial measurement of warrant derivative liabilities in connection to the warrants and pre-funded warrants 51,216,058
Issuance of common stock upon conversion of secured convertible notes 1,343,360
Amounts allocated to common stock purchase warrants in connection with issuance of unsecured promissory note payable $ 20,806